Literature DB >> 11461683

Percentage of CD3+CD4-CD8-gammadeltaTCR- T cells is increased HIV disease.

N D Mathiot1, R Krueger, M A French, P Price.   

Abstract

HIV patients given highly active antiretroviral therapy (HAART) experience a rapid rise in alphabetaT cell numbers, but changes in gammadeltaT cell populations have not been described. Here we investigate the effects of immune reconstitution and immune restoration diseases (IRDs) on expression of a pan-gammadeltaT cell receptor (TCR) marker on double-negative (CD3(+)CD4(-)CD8(-)) T cells and T cells expressing CD4 or CD8. IRDs are inflammatory disorders associated with preexisting infections in patients who have achieved immune reconstitution after HAART. Proportions of CD3(+)CD4(-)CD8(-) T cells and total gammadeltaT cells were not affected by CD4(+) T cell counts, HAART, or a history of IRD, but levels of CD4(-)CD8(-)gammadeltaTCR(-) T cells were higher in patients with <15% CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461683     DOI: 10.1089/088922201750290096

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

Review 1.  Double-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineup.

Authors:  Vasudha Sundaravaradan; Kiran D Mir; Donald L Sodora
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

2.  Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART.

Authors:  Kate Burgess; Patricia Price; Ian R James; Shelley F Stone; Niamh M Keane; Andrew Y F Lim; John R Warmington; Martyn A French
Journal:  J Clin Immunol       Date:  2006-03-28       Impact factor: 8.317

3.  Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine.

Authors:  Steven C Derrick; Teresa H Evering; Vasan K Sambandamurthy; Kripa V Jalapathy; Tsungda Hsu; Bing Chen; Mei Chen; Robert G Russell; Ana Paula Junqueira-Kipnis; Ian M Orme; Steven A Porcelli; William R Jacobs; Sheldon L Morris
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

4.  Induction of Unconventional T Cells by a Mutant Mycobacterium bovis BCG Strain Formulated in Cationic Liposomes Correlates with Protection against Mycobacterium tuberculosis Infections of Immunocompromised Mice.

Authors:  Steven C Derrick; Idalia Yabe; Sheldon Morris; Siobhan Cowley
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

5.  T-cell enumeration from dried blood spots by quantifying rearranged T-cell receptor-beta genes.

Authors:  Andrew D Redd; Emily J Ciccone; Gertrude Nakigozi; Jeanne C Keruly; Anthony Ndyanabo; Boaz Iga; Ronald H Gray; David Serwadda; Thomas C Quinn
Journal:  J Immunol Methods       Date:  2010-01-28       Impact factor: 2.303

6.  Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.

Authors:  Philipp Kaiser; Beda Joos; Barbara Niederöst; Rainer Weber; Huldrych F Günthard; Marek Fischer
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

7.  CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.

Authors:  Siobhán C Cowley; Elizabeth Hamilton; Jeffrey A Frelinger; Jie Su; James Forman; Karen L Elkins
Journal:  J Exp Med       Date:  2005-07-18       Impact factor: 14.307

8.  The clinical correlation of regulatory T cells and cyclic adenosine monophosphate in enterovirus 71 infection.

Authors:  Shih-Min Wang; I-Chun Chen; Yu-Ting Liao; Ching-Chuan Liu
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

9.  Differential alterations in peripheral lymphocyte subsets in COVID-19 patients: upregulation of double-positive and double-negative T cells.

Authors:  Asmaa M Zahran; Zeinab Albadry M Zahran; Yasmeen H Mady; Essam Eldeen M O Mahran; Alaa Rashad; Ahmed Makboul; Khalid A Nasif; Aida A Abdelmaksoud; Omnia El-Badawy
Journal:  Multidiscip Respir Med       Date:  2021-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.